Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromide methylnaltrexone injection for opioid-induced constipation
CTR20181837Phase 3Active
- Sponsor
- Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences. Started Oct 2018; status: active.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on CTR20181837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181837.